Akero Therapeutics
Latest round
- Series B
Last raised
- Dec 2018
Total raised
- $135M
Investors
- 11
About Akero Therapeutics
Founded in 2017 and based in California, US, Akero Therapeutics, Inc. operates as a biotechnology that develops treatment of non-alcoholic steatohepatitis and other metabolic disorders that target the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis. In March 2024, Akero Therapeutics Inc. Akero Therapeutics Inc.65 million shares of common stock as part of the listing. Akero Therapeutics developes therapies for serious metabolic diseases, to improve patients' lives. The company with its lead program, Efruxifermin (EFX), focuses on addressing metabolic dysfunction-associated steatohepatitis (MASH).
Who invested in Akero Therapeutics
11 investors across 2 rounds
See all investors in Akero Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Akero Therapeutics
Who invested in Akero Therapeutics?
Akero Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Akero Therapeutics raised?
Akero Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Akero Therapeutics last raise money?
Akero Therapeutics's most recent round on record is a Series B, in Dec 2018.
What does Akero Therapeutics do?
Founded in 2017 and based in California, US, Akero Therapeutics, Inc.
Where is Akero Therapeutics headquartered?
Akero Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Akero Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Akero Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Akero Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.